Prolia Biosimilar

RALEIGH, N.C., July 23, 2026 Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has announced the commercial...

BENGALURU, India & BRIDGEWATER, N.J. – September 17, 2025 –Biocon Biologics Ltd. (BBL), a global leader in biosimilars and...